Back to Search
Start Over
Circulating sterols as predictors of early allograft dysfunction and clinical outcome in patients undergoing liver transplantation.
- Source :
-
Metabolomics : Official journal of the Metabolomic Society [Metabolomics] 2016; Vol. 12 (12), pp. 182. Date of Electronic Publication: 2016 Oct 24. - Publication Year :
- 2016
-
Abstract
- Introduction: Sensitive and specific assessment of the hepatic graft metabolism after liver transplantation (LTX) is essential for early detection of postoperative dysfunction implying the need for consecutive therapeutic interventions.<br />Objectives: Here, we assessed circulating liver metabolites of the cholesterol pathway, amino acids and acylcarnitines and evaluated their predictive value on early allograft dysfunction (EAD) and clinical outcome in the context of LTX.<br />Methods: The metabolites were quantified in the plasma of 40 liver graft recipients one day pre- and 10 days post-LTX by liquid chromatography/tandem mass spectrometry (LC-MS/MS). Plant sterols as well as cholesterol and its precursors were determined in the free and esterified form; lanosterol in the free form only. Metabolites and esterification ratios were compared to the model for early allograft function scoring (MEAF) which is calculated at day 3 post-LTX from routine parameters defining EAD.<br />Results: The hepatic esterification ratio of all sterols, but not amino acids and acylcarnitine concentrations, showed substantial metabolic disturbances post-LTX and correlated to the MEAF. In ROC analysis, the low esterification ratio of β-sitosterol and stigmasterol from day 1 and of the other sterols from day 3 were predictive for a high MEAF, i.e. EAD. Additionally, the ratio of esterified β-sitosterol and free lanosterol were predictive for all days and the esterification ratio of the other sterols at day 3 or 4 post-LTX for 3-month mortality.<br />Conclusion: Low ratios of circulating esterified sterols are associated with a high risk of EAD and impaired clinical outcome in the early postoperative phase following LTX.<br />Competing Interests: The authors declare no conflict of interest. Ethical approval All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
Details
- Language :
- English
- ISSN :
- 1573-3882
- Volume :
- 12
- Issue :
- 12
- Database :
- MEDLINE
- Journal :
- Metabolomics : Official journal of the Metabolomic Society
- Publication Type :
- Academic Journal
- Accession number :
- 27840599
- Full Text :
- https://doi.org/10.1007/s11306-016-1129-z